Infinity Pharmaceuticals Inc (INFI.OQ)

INFI.OQ on NASDAQ Stock Exchange Global Select Market

22.94USD
1 Aug 2013
Price Change (% chg)

$1.76 (+8.31%)
Prev Close
$21.18
Open
$21.45
Day's High
$23.05
Day's Low
$21.12
Volume
367,702
Avg. Vol
481,915
52-wk High
$50.51
52-wk Low
$14.60

INFI.OQ

Chart for INFI.OQ

About

Infinity Pharmaceuticals, Inc. (IPI) is a drug discovery and development company. The Company's lead product is a potent, oral inhibitor of Class I PI3K-delta and PI3K-gamma, which the Company is investigating in both hematologic malignancies and inflammatory diseases.Its retaspimycin hydrochloride (HCl), is a potent and... (more)

Overall

Beta: 0.67
Market Cap (Mil.): $1,043.02
Shares Outstanding (Mil.): 49.25
Dividend: --
Yield (%): --

Financials

  INFI.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -1.74 -- --
ROI: -36.86 -2.58 18.76
ROE: -47.63 -2.66 19.59
Search Stocks

BRIEF-Infinity Pharma shares off 4.1 pct premarket

NEW YORK, April 11 - Infinity Pharmaceuticals Inc : * Shares off 4.1 percent premarket after pricing of secondary offering

11 Apr 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$472.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks